MedPlus Health Services announced that its subsidiary, Optival Health Solutions Private Limited, received a temporary suspension order for a Drug License in Maharashtra. The suspension impacts one store located in Sangvi, Pune, and is effective for seven days. The authority cited a violation under the Drugs and Cosmetics Act, 1940. The company estimates the potential revenue loss associated with this temporary shutdown to be approximately Rs 3.85 lacs.
Regulatory Update on Subsidiary Operations
MedPlus Health Services Limited has issued a mandatory disclosure regarding regulatory action taken against one of its retail outlets operated by its subsidiary, Optival Health Solutions Private Limited. The action taken by the Assistant Commissioner & Licensing authority, Food & Drug Administration in Pune, Maharashtra, involves the Suspension of a Drug License.
Details of the Suspension Order
The specific store affected by the order is situated at Sangvi, Pune, Maharashtra. The suspension period mandated by the authority is for a duration of seven days. The company received the official order on 03.03.2026. The alleged contravention cited falls under Rule 65 of the Drugs and Cosmetics Act, 1940, and the associated Rules of 1945.
Financial Impact Assessment
While the matter is not quantifiable in monetary terms to the extent of a permanent loss, the management has quantified the immediate impact. The anticipated Potential Revenue Loss resulting from this seven-day closure is estimated to be Rs 3.85 lacs. The company confirmed that all requisite disclosures have been made on its website and the stock exchanges as per mandated timelines.
Source: BSE
